Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Franssen

Showing results (231-240 of 392) with videos related to

Pageof 40
Sort By:
Pulmonary Pharmacology & Therapeutics|December 1, 2019
C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPDOlorunfemi A Oshagbemi, Frits M E Franssen, Emiel F M Wouters, et al.
The European Respiratory Journal|May 7, 2013
Plasma advanced glycation end-products and skin autofluorescence are increased in COPDPoornima Gopal, Niki L Reynaert, Jean L J M Scheijen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 25, 2017
Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZD C W Braeken, F M E Franssen, H von Baum, et al.
ERJ Open Research|May 3, 2017
Clinical highlights from the 2016 European Respiratory Society International CongressNicolas Kahn, Laura Fregonese, Miriam Barrecheguren, et al.
Journal of the American Medical Directors Association|February 26, 2017
Normal Weight but Low Muscle Mass and Abdominally Obese: Implications for the Cardiometabolic Risk Profile in Chronic Obstructive Pulmonary DiseaseRosanne J H C G Beijers, Coby van de Bool, Bram van den Borst, et al.
Bone Marrow Transplantation|March 24, 2015
The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIsL E Franssen, N W C J van de Donk, M E Emmelot, et al.
Plos One|March 15, 2024
Alterations in stride-to-stride fluctuations in patients with chronic obstructive pulmonary disease during a self-paced treadmill 6-minute walk testWai-Yan Liu, Martijn A Spruit, Jeannet M Delbressine, et al.
ERJ Open Research|January 6, 2023
All-cause admissions following a first ever exacerbation-related hospitalisation in COPDKiki Waeijen-Smit, Peter A Jacobsen, Sarah Houben-Wilke, et al.
Bone|February 21, 2018
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary diseaseOlorunfemi A Oshagbemi, Andrea M Burden, Kimberly N Shudofsky, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 23, 2017
Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosisO A Oshagbemi, J H M Driessen, A Pieffers, et al.
Pageof 40

Showing results (231-240 of 392) with videos related to

Sort By:
Pageof 40
Pulmonary Pharmacology & Therapeutics|December 1, 2019
C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPDOlorunfemi A Oshagbemi, Frits M E Franssen, Emiel F M Wouters, et al.
The European Respiratory Journal|May 7, 2013
Plasma advanced glycation end-products and skin autofluorescence are increased in COPDPoornima Gopal, Niki L Reynaert, Jean L J M Scheijen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 25, 2017
Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZD C W Braeken, F M E Franssen, H von Baum, et al.
ERJ Open Research|May 3, 2017
Clinical highlights from the 2016 European Respiratory Society International CongressNicolas Kahn, Laura Fregonese, Miriam Barrecheguren, et al.
Journal of the American Medical Directors Association|February 26, 2017
Normal Weight but Low Muscle Mass and Abdominally Obese: Implications for the Cardiometabolic Risk Profile in Chronic Obstructive Pulmonary DiseaseRosanne J H C G Beijers, Coby van de Bool, Bram van den Borst, et al.
Bone Marrow Transplantation|March 24, 2015
The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIsL E Franssen, N W C J van de Donk, M E Emmelot, et al.
Plos One|March 15, 2024
Alterations in stride-to-stride fluctuations in patients with chronic obstructive pulmonary disease during a self-paced treadmill 6-minute walk testWai-Yan Liu, Martijn A Spruit, Jeannet M Delbressine, et al.
ERJ Open Research|January 6, 2023
All-cause admissions following a first ever exacerbation-related hospitalisation in COPDKiki Waeijen-Smit, Peter A Jacobsen, Sarah Houben-Wilke, et al.
Bone|February 21, 2018
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary diseaseOlorunfemi A Oshagbemi, Andrea M Burden, Kimberly N Shudofsky, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 23, 2017
Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosisO A Oshagbemi, J H M Driessen, A Pieffers, et al.
Pageof 40